Publications by authors named "Jean Francois Nicolas"

Severe cutaneous adverse reactions to drugs (SCARs) are rare but life-threatening delayed allergies. While they primarily affect the skin, they can also affect internal organs. Accordingly, they present with diverse clinical symptoms that vary not only between SCARs subtypes but also among patients.

View Article and Find Full Text PDF
Article Synopsis
  • Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe, rare skin reactions primarily triggered by drugs, leading to significant health risks and complications.
  • The review suggests new diagnostic criteria to better identify these conditions and highlights recent research on how specific immune responses and genetic factors contribute to their development.
  • It also discusses current and emerging treatment options, including debates on immunosuppressive therapies and new drug developments targeting specific mechanisms involved in SJS/TEN, advocating for a more collaborative approach in medical research to improve patient care.
View Article and Find Full Text PDF

Background: We evaluated co-administration of adjuvanted seasonal quadrivalent influenza vaccine (FLU-aQIV) and respiratory syncytial virus (RSV) prefusion F protein-based vaccine (RSVPreF3 OA) in ≥65-year-olds.

Methods: This phase 3, open-label trial randomized ≥65-year-olds to receive FLU-aQIV and RSVPreF3 OA concomitantly (Co-Ad) or sequentially, 1 month apart (Control). Primary objectives were to demonstrate the non-inferiority of FLU-aQIV and RSVPreF3 OA co-administration versus sequential administration in terms of hemagglutination inhibition (HI) titers for each FLU-aQIV strain and RSV-A and RSV-B neutralization titers, 1 month post-vaccination.

View Article and Find Full Text PDF

Background: The contribution of Staphylococcus aureus to the exacerbation of atopic dermatitis (AD) is widely documented, but its role as a primary trigger of AD skin symptoms remains poorly explored.

Objectives: This study sought to reappraise the main bacterial factors and underlying immune mechanisms by which S aureus triggers AD-like inflammation.

Methods: This study capitalized on a preclinical model, in which different clinical isolates were applied in the absence of any prior experimental skin injury.

View Article and Find Full Text PDF

Importance: There is still considerable controversy in the literature regarding the capacity of intramuscular messenger RNA (mRNA) vaccination to induce a mucosal immune response.

Objective: To compare serum and salivary IgG and IgA levels among mRNA-vaccinated individuals with or without previous SARS-CoV-2 infection.

Design, Setting, And Participants: In this cohort study, SARS-CoV-2-naive participants and those with previous infection were consecutively included in the CoviCompare P and CoviCompare M mRNA vaccination trials and followed up to day 180 after vaccination with either the BNT162b2 (Pfizer-BioNTech) vaccine or the mRNA-1273 (Moderna) vaccine at the beginning of the COVID-19 vaccination campaign (from February 19 to June 8, 2021) in France.

View Article and Find Full Text PDF

Empty mast cell syndrome, also named post anaphylaxis mast cell anergy (PAMA), is a temporary state of loss of mast cell responsiveness after a severe immediate hypersensitivity reaction. In this study, we describe a case of PAMA after accidental re-exposure to amoxicillin in a patient who developed severe anaphylaxis to this drug three days earlier in the operating room. To our knowledge, this report is the second to document this phenomenon.

View Article and Find Full Text PDF
Article Synopsis
  • The ANRS|MIE CoviCompareP study investigated COVID-19 breakthrough infections among vaccinated adults during the Omicron variant's circulation, focusing on those vaccinated with the Pfizer-BioNTech vaccine.
  • The study involved healthy adults divided into groups based on previous SARS-CoV-2 infection status and monitored their neutralizing antibodies after vaccination and boosters.
  • Results showed that 31% of participants experienced breakthrough infections, with lower infection risks linked to older age, more booster doses, and higher neutralizing antibody levels, especially in those with prior infections.
View Article and Find Full Text PDF
Article Synopsis
  • This study monitored long-term safety data from participants who received the Ebola vaccines Ad26.ZEBOV and/or MVA-BN-Filo across 15 sites in seven countries.
  • A total of 614 adults were followed for 60 months post-vaccination, revealing that 8% experienced at least one serious adverse event (SAE), with a specific incidence rate calculated.
  • The study found no major safety concerns, as there were no deaths or life-threatening SAEs, and only one SAE was related to the vaccines, indicating their long-term safety.
View Article and Find Full Text PDF
Article Synopsis
  • - Atopic dermatitis (AD) is a chronic skin condition that often coexists with ocular surface diseases (OSD), yet the prevalence and referral criteria for OSD in AD patients needing treatment are unclear.
  • - A study examined 98 AD patients and found that 85% had OSD, with the most common issues being dry eye syndrome and allergic conjunctivitis, even in patients who didn’t report eye symptoms.
  • - Identified risk factors for developing OSD include history of allergic rhinitis, sensitization, and certain ocular symptoms, suggesting that AD patients may need regular eye evaluations, especially before starting type 2 inflammation therapies.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aims to distinguish between allergic and nonallergic Contact Dermatitis (CD) by analyzing molecular signatures in skin lesions of patients, using patch-testing for diagnosis.
  • - Researchers tested 12 allergy biomarkers in lesions from 38 CD patients, finding two patterns: one group showed allergy signatures that correlated with acute allergic reactions, while another group did not.
  • - The findings suggest that identifying these molecular signatures could improve patient management by helping to predict those with allergic CD, potentially simplifying treatment approaches.
View Article and Find Full Text PDF

Background: Tissue-resident memory T (T ) cells are detrimental in allergic contact dermatitis (ACD), in which they contribute to the chronicity and severity of the disease.

Methods: We assessed the impact of a standard topical corticosteroid (TCS) treatment, triamcinolone acetonide (TA), on the formation, maintenance and reactivation of epidermal T cells in a preclinical model of ACD to 2,4-dinitrofluorobenzene. TA 0.

View Article and Find Full Text PDF

Importance: The pathogenesis of eosinophilic cellulitis (EC) is poorly understood, limiting available treatment options. The current treatment paradigm focuses on delayed type 2 hypersensitivity reaction to various triggers.

Objective: To gain further insight into the nature of EC inflammation and into the cellular signal transduction pathways that are activated in the context of EC.

View Article and Find Full Text PDF

Skin metabolites (< 1500 Da) play a critical role in barrier function, hydration, immune response, microbial invasion, and allergen penetration. We aimed to understand the global metabolic profile changes of the skin in relation to the microbiome and UV exposure and exposed germ-free (devoid of microbiome), disinfected mice (partially devoid of skin microbiome) and control mice with intact microbiome to immunosuppressive doses of UVB radiation. Targeted and untargeted lipidome and metabolome profiling was performed with skin tissue by high-resolution mass spectrometry.

View Article and Find Full Text PDF

Like in many fields of medicine, the concept of precision dosing has re-emerged in routine practice in allergology. Only one retrospective study on French physicians' practice has addressed this topic so far and generated preliminary data supporting dose adaptation, mainly based on experience, patient profile understanding and response to treatment. Both intrinsic and extrinsic factors shape the individual immune system response to allergen immunotherapy (AIT).

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a common chronic inflammatory skin disease that significantly affects the patient's quality of life. A disrupted skin barrier, type 2 cytokine-dominated inflammation, and microbial dysbiosis with increased colonization are critical components of AD pathogenesis. Patients with AD exhibit decreased expression of antimicrobial peptides (AMPs) which is linked to increased colonization by .

View Article and Find Full Text PDF

Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65-84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost.

View Article and Find Full Text PDF

The cutaneous microbiota contributes to skin barrier function, ensuring effective protection against pathogens and contributing to the maintenance of epidermal integrity. Dysbiosis is frequently present in atopic dermatitis (AD), a chronic inflammatory disease associated with skin barrier defects. Dysbiosis is associated with reduced bacterial diversity and marked Staphylococcus aureus colonization, which is favoured in the case of certain local AD-specific properties such as reduced skin acidity, eased bacterial adhesion and decreased antimicrobial peptide production.

View Article and Find Full Text PDF

Background: Epicutaneous immunotherapy (EPIT) protocols have recently been developed to restore tolerance in patients with food allergy. The mechanisms by which EPIT protocols promote desensitization rely on a profound immune deviation of pathogenic T- and B-cell responses.

Objective: To date, little is known about the contribution of skin dendritic cells (skDCs) to T-cell remodeling and EPIT efficacy.

View Article and Find Full Text PDF

Patients with polymorphic light eruption (PLE) develop lesions upon the first exposure to sun in spring/summer, but lesions usually subside during season due to the natural (or medical) photohardening. However, these lesions tend to reappear the following year and continue to do so in most patients, suggesting the presence of a disease memory. To study the potential role of skin resident memory T cells (Trm), we investigated the functional phenotype of Trm and the expression of IL-15 in PLE.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the reliability of patch tests for diagnosing contact allergy to Amerchol L-101 (AL-101), a potential marker for lanolin allergy.
  • A dose-response re-test was performed on 10 subjects, revealing that 8 exhibited positive allergic reactions, often tied to specific gene activity associated with immune response.
  • The findings suggest that while AL-101 is an allergen causing both allergy and irritation, molecular profiling could enhance the accuracy of clinical diagnoses.
View Article and Find Full Text PDF

Red blood cell exchanges are frequently used to treat and prevent cerebrovascular complications in patients with sickle cell anemia (SCA). However, the low weight of young children represents serious concerns for this procedure. The Spectra Optia device can perform automatic priming using red blood cells (RBCs) (RCE/RBC-primed) which could allow RBC exchanges (RCE) to be performed in young children without hypovolemic complications, but this method requires evaluation.

View Article and Find Full Text PDF